Purchase of IFF again when you sell a pharma unit – but no more 'frutaroms'




On the phone with Wall Street analysts after the Fortune 500 company reported its results 2024, CEO Erik Fyrwald made it clear that the purchase was back on the table – but in a more disciplined way. Read more



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *